National Research ( (NRC) ) has released its Q4 earnings. Here is a breakdown of the information National Research presented to its investors.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
National Research Corporation, operating as NRC Health, is a leader in humanizing healthcare services by providing insightful market research and understanding consumer preferences in the healthcare sector. In the fourth quarter of 2024, NRC Health reported a slight decline in revenue to approximately $36.9 million from $38.0 million the previous year, alongside a decrease in earnings per diluted share from $0.36 to $0.28. The company maintained its strategic focus on shareholder returns, repurchasing 393,000 shares for around $7.3 million and distributing $2.8 million in dividends. Despite a decline in revenue and net income, NRC Health continues to show robust recurring contract value at $133.2 million, demonstrating its continued relevance and engagement in the healthcare market. The management remains focused on its strategic initiatives to drive growth and enhance shareholder value while navigating market challenges.
